Research Summary

The Pharmaceutical Biotechnology Center (PBC) addresses human and animal health concerns through development of bio-therapeutics (monoclonal antibodies, peptides, proteins) and vaccines, with emphasis on cardiometabolic diseases, diabetes and nutritional health.

The objectives are to:

  1. Establish integrated capabilities for preclinical assessment and clinical lead development of bio-therapeutics and vaccines in collaboration with academic researchers or industrial customers;
  2. Become the preferred partner and a conduit for pharmaceutical product development bridging academia and industry;
  3. Become a preferred partner for industries for the discovery as well as product and pipeline development; and
  4. Become an economic engine facilitating therapeutics development and startup businesses.

Learn about the PBC's access to Eli Lilly and Company's Fab Phage Display Library and the IBRI's other core technologies.

Lab Team